Body dysmorphic disorder (BDD) is a relative contraindication for facial plastic surgery, but formal detection is not common in practice. The prevalence of BDD in patients seeking facial plastic surgery is not well documented. Patients with BDD are very vulnerable and often experience distress that hinders their daily functioning and social interactions. This condition can cause distorted self-perception, as people with BDD tend to focus too much on small details and not see the big picture.
They may adopt repetitive behaviors, such as looking too much in the mirror or avoiding photographs, all in an attempt to address or hide their perceived flaws. Cosmetic interventions of all kinds are increasingly accessible to a wider audience. Therefore, it would be ideal for aesthetic specialists to routinely perform tests to detect body dysmorphic disorder. This prospective cohort study attempts to establish the prevalence of body dysmorphic disorder in facial plastic and oculoplastic surgery offices and to estimate the ability of surgeons to detect it.
This instrument was originally developed and validated in the psychiatric environment, but has since been validated in several patient populations, including the population of facial plastic and reconstructive surgery patients. Body dysmorphic disorder is a common condition in facial plastic surgery offices, but surgeons have little precision in identifying these patients compared to validated screening instruments. Surgeons should pay special attention to patients who have tested positive for BDD to determine if there is a true indication for surgery, as it has been demonstrated that most patients with BDD do not benefit from cosmetic surgery and feel dissatisfied after surgery. Not surprisingly, in the same survey by the American Society for Aesthetic Plastic Surgery mentioned above, 84% of plastic surgeons reported having performed surgery without knowing it.
to patients with TDC. The routine implementation of validated screening instruments in the clinical workflow of facial plastic and oculoplastic surgery practices may result in better patient care. Study Center 1 represents an academic office for facial plastic and reconstructive surgery; Site 2, a private office for facial plastic and reconstructive surgery; and Site 3, an academic office for oculoplastic surgery. Establish the prevalence of BDD in facial plastic and oculoplastic surgery offices, and estimate the ability of surgeons to detect BDD. The reported prevalence of BDD in patients undergoing facial plastic and oculoplastic surgery varies significantly, probably due to different patient populations and the inconsistency of detection methods.
However, the BDDQ is a validated detection instrument in the field of facial plastic surgery with a very high sensitivity and specificity. Among the population dedicated to facial plastic and reconstructive surgery, it was found that it had a very high sensitivity (100%) and a high specificity (90.3%). Body dysmorphic disorder is a common condition in patients who undergo facial plastic and oculoplastic surgery. More recent studies suggest that the prevalence of BDD is up to 13% in the facial plastic surgery environment and 6.9% in the practice of surgery oculoplastic.
